Brixton Biosciences
Latest round
- Series B
Last raised
- May 2024
Total raised
- $33M
Investors
- 6
About Brixton Biosciences
Founded in 2019 by co-founder Sameer Sabir and based in Massachusetts, US, Brixton Biosciences, Inc. is a provider of a therapy designed to provide pain relief through a targeted injection. In May 2024, Brixton Biosciences, Inc.08 million post-money. The primary product of Brixton Biosciences is neural ice, an injectable solution designed to deliver targeted pain relief through a process called cryoneurolysis. This technique involves using a specialized ice slurry to induce temporary desensitization of nerves, which provides pain relief. The approach addresses acute and chronic pain conditions by leveraging selective cryoneurolysis to desensitize pain in specific areas.
Who invested in Brixton Biosciences
6 investors across 1 round
See all investors in Brixton Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
May 14, 2024
Amount
$33M
Investors
Questions about Brixton Biosciences
Who invested in Brixton Biosciences?
Brixton Biosciences has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Brixton Biosciences raised?
Brixton Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Brixton Biosciences last raise money?
Brixton Biosciences's most recent round on record is a Series B, in May 2024.
What does Brixton Biosciences do?
Founded in 2019 by co-founder Sameer Sabir and based in Massachusetts, US, Brixton Biosciences, Inc.
Where is Brixton Biosciences headquartered?
Brixton Biosciences is headquartered in Cambridge, US.
Which VCs invest in companies like Brixton Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Brixton Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Brixton Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.